Lygm – Environmental Projects Ltd. Files Early Warning Report with Respect to IM Cannabis Corp.
BEIT LECHEM HAGLILIT, ISRAEL, June 27, 2025 / EINPresswire.com / -- This press release is issued pursuant to Multilateral Instrument 62-104 – Take-Over Bids and Issuer Bids and National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues.
Lygm – Environmental Projects Ltd. (the 'Acquiror'), a privately held entity controlled by Ran Molho (the 'Joint Actor'), has acquired 575,461 common shares (the 'Common Shares') in the capital of IM Cannabis Corp. (the 'Company') on June 24, 2025, pursuant to the conversion of a debenture in the principal amount of $1,501,953.20 at a deemed price of C$2.61 per Common Share, maturing on May 26, 2026, (the 'Acquisition'). As a result of the Acquisition, the Acquiror, along with the Joint Actor, now owns and controls 10% or more of the Common Shares of the Company.
Immediately prior to the Acquisition, the Acquiror, along with the Joint Actor, beneficially owned, or exercised control and direction over, 130,210 Common Shares, and 129,705 warrants in the capital of the Issuer (each, a 'Warrant'), representing approximately 3.75% of the issued and outstanding Common Shares of the Issuer on an undiluted basis, and approximately 7.22% on a partially diluted basis.
Following the Acquisition, after acquiring an additional 575,461 Common Shares, the Acquiror now beneficially owns, or exercises control and direction over, 705,671 Common Shares and 129,705 Warrants, representing approximately 17.45% of the issued and outstanding Common Shares of the Issuer on an undiluted basis, and approximately 20.01% on a partially diluted basis.
The Common Shares that have been acquired by the Acquiror, together with any Common Shares acquired, held, directed, or controlled by the Joint Actor, are being held for investment purposes. In the future, the Acquiror and/or Joint Actor may, from time to time and depending on market and other conditions, acquire or dispose of additional Common Shares and/or other equity, debt, or other securities or instruments of the Issuer in market transactions, private agreements or otherwise, and reserves the right to engage in similar transactions with respect to the securities.
This news release is being issued under the warning provisions of Canadian securities legislation. A copy of the corresponding early warning report will be filed and made available under the Acquiror's profile on SEDAR+ at www.sedarplus.ca.
For more information, or to obtain a copy of the early warning report, please contact:
Ran Molho
Phone: +97249059397
E-mail: [email protected]
Ran Molho
Lygm – Environmental Projects Ltd.
+972 4-905-9397
email us here
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
40 minutes ago
- Yahoo
Cleo Diagnostics (ASX:COV) Is In A Good Position To Deliver On Growth Plans
Just because a business does not make any money, does not mean that the stock will go down. For example, although made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. Having said that, unprofitable companies are risky because they could potentially burn through all their cash and become distressed. Given this risk, we thought we'd take a look at whether Cleo Diagnostics (ASX:COV) shareholders should be worried about its cash burn. In this report, we will consider the company's annual negative free cash flow, henceforth referring to it as the 'cash burn'. Let's start with an examination of the business' cash, relative to its cash burn. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. You can calculate a company's cash runway by dividing the amount of cash it has by the rate at which it is spending that cash. When Cleo Diagnostics last reported its December 2024 balance sheet in February 2025, it had zero debt and cash worth AU$7.3m. In the last year, its cash burn was AU$2.8m. That means it had a cash runway of about 2.6 years as of December 2024. That's decent, giving the company a couple years to develop its business. The image below shows how its cash balance has been changing over the last few years. Check out our latest analysis for Cleo Diagnostics While Cleo Diagnostics did record statutory revenue of AU$211k over the last year, it didn't have any revenue from operations. To us, that makes it a pre-revenue company, so we'll look to its cash burn trajectory as an assessment of its cash burn situation. During the last twelve months, its cash burn actually ramped up 58%. Oftentimes, increased cash burn simply means a company is accelerating its business development, but one should always be mindful that this causes the cash runway to shrink. Cleo Diagnostics makes us a little nervous due to its lack of substantial operating revenue. So we'd generally prefer stocks from this list of stocks that have analysts forecasting growth. While Cleo Diagnostics does have a solid cash runway, its cash burn trajectory may have some shareholders thinking ahead to when the company may need to raise more cash. Companies can raise capital through either debt or equity. Commonly, a business will sell new shares in itself to raise cash and drive growth. We can compare a company's cash burn to its market capitalisation to get a sense for how many new shares a company would have to issue to fund one year's operations. Cleo Diagnostics' cash burn of AU$2.8m is about 5.4% of its AU$51m market capitalisation. That's a low proportion, so we figure the company would be able to raise more cash to fund growth, with a little dilution, or even to simply borrow some money. As you can probably tell by now, we're not too worried about Cleo Diagnostics' cash burn. For example, we think its cash runway suggests that the company is on a good path. Although its increasing cash burn does give us reason for pause, the other metrics we discussed in this article form a positive picture overall. Based on the factors mentioned in this article, we think its cash burn situation warrants some attention from shareholders, but we don't think they should be worried. On another note, we conducted an in-depth investigation of the company, and identified 3 warning signs for Cleo Diagnostics (1 is a bit concerning!) that you should be aware of before investing here. Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies with significant insider holdings, and this list of stocks growth stocks (according to analyst forecasts) — Investing narratives with Fair Values A case for TSXV:USA to reach USD $5.00 - $9.00 (CAD $7.30–$12.29) by 2029. By Agricola – Community Contributor Fair Value Estimated: CA$12.29 · 0.9% Overvalued DLocal's Future Growth Fueled by 35% Revenue and Profit Margin Boosts By WynnLevi – Community Contributor Fair Value Estimated: $195.39 · 0.9% Overvalued Historically Cheap, but the Margin of Safety Is Still Thin By Mandelman – Community Contributor Fair Value Estimated: SEK232.58 · 0.1% Overvalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
The Trend Of High Returns At Mainfreight (NZSE:MFT) Has Us Very Interested
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an eye out for. Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. Put simply, these types of businesses are compounding machines, meaning they are continually reinvesting their earnings at ever-higher rates of return. And in light of that, the trends we're seeing at Mainfreight's (NZSE:MFT) look very promising so lets take a look. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. Analysts use this formula to calculate it for Mainfreight: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.25 = NZ$799m ÷ (NZ$4.1b - NZ$852m) (Based on the trailing twelve months to March 2025). Therefore, Mainfreight has an ROCE of 25%. That's a fantastic return and not only that, it outpaces the average of 11% earned by companies in a similar industry. Check out our latest analysis for Mainfreight Above you can see how the current ROCE for Mainfreight compares to its prior returns on capital, but there's only so much you can tell from the past. If you'd like, you can check out the forecasts from the analysts covering Mainfreight for free. The trends we've noticed at Mainfreight are quite reassuring. Over the last five years, returns on capital employed have risen substantially to 25%. Basically the business is earning more per dollar of capital invested and in addition to that, 84% more capital is being employed now too. The increasing returns on a growing amount of capital is common amongst multi-baggers and that's why we're impressed. To sum it up, Mainfreight has proven it can reinvest in the business and generate higher returns on that capital employed, which is terrific. And investors seem to expect more of this going forward, since the stock has rewarded shareholders with a 88% return over the last five years. So given the stock has proven it has promising trends, it's worth researching the company further to see if these trends are likely to persist. On a separate note, we've found 1 warning sign for Mainfreight you'll probably want to know about. If you'd like to see other companies earning high returns, check out our free list of companies earning high returns with solid balance sheets here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
CNBC
2 hours ago
- CNBC
The record-breaking week in the stock market that could have gone very badly
It was another exciting week on Wall Street as the S & P 500 and Nasdaq each closed Friday at new record highs. Incredible as that was, this week could have easily gone another way. Last Saturday, the world learned that the U.S. had entered the Israel-Iran conflict, dropping several massive bunker busters on Fordo, Iran's underground nuclear facility buried under a mountain, and bombing two other sites, Isfahan and Natanz. While fear of further escalation and a prolonged war involving the U.S. was palpable last weekend, the market on Monday shrugged, betting on the notion that the conflict would not result in systemic risk or slow the U.S. economy and hamper corporate earnings much, if at all. As risky as any military action is given the potential to spiral out of control, they tend not to impact the market for long, unless signs appear that it will start impacting growth and inflation. That has not yet happened. We did see energy prices surge in the week before last Saturday's bombings, but they quickly came back down. West Texas Intermediate crude plunged on Monday and Tuesday. While rising modestly in each subsequent session, WTI plunged more than 11% for the week, breaking a three-week winning streak. The stock market took its cues from oil trading, which allowed for the S & P 500 and Nasdaq records and weekly gains of nearly 3.5% and more than 4%, respectively. Monday is the last day of June and Wall Street's second quarter. For the week ... S & P 500 week to date (WTD) up 3.44%; first positive week in three Month to date (MTD) up 4.42%; on pace for its second positive month in a row Quarter to date (QTD) up 10%; on pace for its best quarter since first quarter 2024 Nasdaq WTD up 4.25% MTD up 6%; on pace for its third positive month in a row QTD up 17.2%; best quarter since second quarter 2020 Energy represents a major input cost, often one of the largest, for just about every business in the world, so a sustained increase in energy prices would crunch profit margins or force price hikes in order to preserve them. At the same time, it represents a large unavoidable cost for consumers, whether they're trying to air condition their homes in the summer, heat their homes in the winter, or fill up their cars. Given these high priority needs, elevated energy costs end up cutting into discretionary budgets – meaning activities such as eating out or shopping would get cut back. The quick pairing back of those energy price increases this past week, however, means that analysts don't need to downwardly revise estimates for growth, inflation, or consumer spending – at least not yet. The full impact of President Donald Trump 's tariffs is still unclear, though they will almost certainly lead to higher prices for consumers. While the de-escalation of tensions in the Mideast, and subsequent pullback in energy prices, were certainly the most important factors supporting this week's market action, interest rate expectations were also in focus. Though several voting members of the Federal Reserve's policymaking committee, including Fed Chairman Jerome Powell , threw cold water on comments from Fed Governors Christopher Waller and Michelle Bowman that they were on board with a July rate cut, investors have nonetheless started to price in a higher likelihood that we see three Fed rate cuts by year-end, up from the odds of just two cuts only a week ago. That's according to the CME FedWatch Tool . Another important update that could influence interest rate decisions came Friday, with the release of the May personal income and spending report. Within that report, we find the personal consumption expenditures (PCE) price index, the Fed's preferred measure of inflation. While headline PCE was in line with expectations, up 0.1% month over month and up 2.3% annually, the core rate was a bit hotter than expected, rising 0.2% month over month and 2.7% versus the year-ago period, both one-tenth of a percentage point above expectations. The warmer core reading, which excludes food and energy, is something to watch and cuts against the case for a July rate cut. Digging into the portfolio, we hosted our June Monthly Meeting this week, providing a rundown of all 30 holdings. Jim Cramer highlighted six rallying stocks that members may want to consider booking profits in, and five others that look like buys. We also answered key member questions and touched on all 10 names in our Bullpen, including Cisco Systems, which was added on Monday . The Bullpen is our watch list of stocks that could, under the right circumstances, join the Charitable Trust. During the June meeting, Jim was itching to buy Cisco and Boeing but decided to wait. Sticking with portfolio updates, Nvidia hit new all-time highs this past week as sentiment around artificial intelligence and data center demand continued to improve. Analysts at Loop Capital slapped a $250-per-share price target on the stock, highlighting the hyperscaler purchase intentions over the next few years, the compute intensity of reasoning models, and increased inference demand resulting from AI agent adoption. Already regaining the title of the most valuable U.S. public company at more than $3.8 trillion, Nvidia at $250 represents roughly 60% upside to Friday $157 close and a market cap of more than $6 trillion. Needless to say, Nvidia was our top performer for the week up more than 9.5%. Data center plays — Eaton, GE Vernova, and Broadcom are also expected to benefit from the AI strong demand. On Tuesday, analysts at Morgan Stanley raised their price target on GE Vernova, while analysts at HSBC upgraded Broadcom to a buy from a hold rating. Broadcom, Eaton , and GE Vernova were our next best stocks for the week. Goldman Sachs rounded out the week's top five as financial stocks got some incrementally positive news this week when the Fed, on Wednesday, proposed lowering capital requirements for large U.S banks that were implemented in the years following the 2008 financial crisis. The move would allow banks, including Club holdings Goldman and Wells Fargo , to lend more freely while making it easier for them to buy more U.S. government bonds. Amazon continues to be in the news as investors work to better understand the opportunity the company has in new areas like online grocery shopping, thanks to its massive logistics network and the implications of advancing it through generative AI, robotics and autonomous vehicles. In health care, shares of Eli Lilly advanced this week despite data released Monday on the company's experimental weight-loss drug, bimagrumab, which is designed to help patients preserve muscle mass. It failed to wow investors. Abbott Laboratories , meanwhile, got some positive news Tuesday when Health & Human Services Secretary Robert F. Kennedy Jr. said that his department will encourage the use of wearable health devices. "My vision is every American is wearing a wearable within four years," RFK Jr. said at a House Energy and Commerce Committee meeting . The news may also bode well for devices like the Apple Watch, especially as more health-related sensors are built in. Speaking of Apple , we still believe it is an incredible company with the "greatest product in the world," as Jim put it , referring to the iPhone. However, we think the company would benefit from modifying its capital allocation plans , focusing less on the buyback and more on AI development, be it via internal R & D, paying up for top talent, or acquiring groundbreaking startups. (See here for a full list of the stocks in Jim Cramer's Charitable Trust.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
